Firsthand Technology Value Fund, Inc. (SVVC)

11.68
0.13 1.16
NASDAQ
Prev Close 11.55
Open 11.56
Day Low/High 11.56 / 11.75
52 Wk Low/High 7.29 / 12.74
Volume 19.38K
Exchange NASDAQ
Shares Outstanding 7.30B
Market Cap 84.41M
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CRWS, EGOV, HIFR, MATX, SVVC, TMST Downgrades: BANC, LMT, TCMD Initiations: BAS Read on to get TheStreet Quant Ratings' detailed report:

Firsthand Technology Value Fund Discloses Preliminary NAV Of $23.83 Per Share As Of December 31, 2017

Firsthand Technology Value Fund Discloses Preliminary NAV Of $23.83 Per Share As Of December 31, 2017

Top Holdings Include Pivotal, QMAT, IntraOp, Nutanix, and Revasum

Firsthand Technology Value Fund Discloses Preliminary NAV Of $18.74 Per Share As Of September 30, 2017

Firsthand Technology Value Fund Discloses Preliminary NAV Of $18.74 Per Share As Of September 30, 2017

Top Holdings Include Pivotal Systems, IntraOp Medical, QMAT, Wrightspeed, and Nutanix

Firsthand Technology Value Fund Discloses Preliminary NAV Of $18.81 Per Share As Of June 30, 2017

Firsthand Technology Value Fund Discloses Preliminary NAV Of $18.81 Per Share As Of June 30, 2017

Top Holdings Include Pivotal Systems, IntraOp Medical, QMAT, Wrightspeed, and Nutanix

Firsthand Technology Value Fund Discloses Preliminary NAV Of $20.03 Per Share As Of March 31, 2017

Top Holdings Include IntraOp Medical, Pivotal Systems, Turn, QMAT, and Wrightspeed

Quant Rating on 3:32 PM EDT 5/24/2018

From Our Partners

TheStreet Quant Rating: B- (Buy)